Search research articles
Contact Us
Filters
Showing results (131-140 of 162) with videos related to
Page
of 17
Sort By:
The New England Journal of Medicine
|
December 17, 2008
Effect of aspirin or resistant starch on colorectal neoplasia in the Lynch syndrome
John Burn, D Timothy Bishop, Jukka-Pekka Mecklin, et al.
The New England Journal of Medicine
|
September 9, 2020
Eflornithine plus Sulindac for Prevention of Progression in Familial Adenomatous Polyposis
Carol A Burke, Evelien Dekker, Patrick Lynch, et al.
The Lancet. Oncology
|
November 13, 2012
Long-term effect of resistant starch on cancer risk in carriers of hereditary colorectal cancer: an analysis from the CAPP2 randomised controlled trial
John C Mathers, Mohammad Movahedi, Finlay Macrae, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 3, 2006
Germ line mutations of mismatch repair genes in hereditary nonpolyposis colorectal cancer patients with small bowel cancer: International Society for Gastrointestinal Hereditary Tumours Collaborative Study
Jae-Gahb Park, Duck-Woo Kim, Chang Won Hong, et al.
Science (New York, N.Y.)
|
November 8, 2008
GENETICS. The Human Variome Project
Richard G H Cotton, Arleen D Auerbach, Myles Axton, et al.
Human Mutation
|
February 12, 2019
A sensitive and scalable microsatellite instability assay to diagnose constitutional mismatch repair deficiency by sequencing of peripheral blood leukocytes
Richard Gallon, Barbara Mühlegger, Sören-Sebastian Wenzel, et al.
The British Journal of Surgery
|
May 9, 2024
Updated European guidelines for clinical management of familial adenomatous polyposis (FAP), MUTYH-associated polyposis (MAP), gastric adenocarcinoma, proximal polyposis of the stomach (GAPPS) and other rare adenomatous polyposis syndromes: a joint EHTG-ESCP revision
Gloria Zaffaroni, Alessandro Mannucci, Laura Koskenvuo, et al.
Lancet (London, England)
|
November 1, 2011
Long-term effect of aspirin on cancer risk in carriers of hereditary colorectal cancer: an analysis from the CAPP2 randomised controlled trial
John Burn, Anne-Marie Gerdes, Finlay Macrae, et al.
Gut
|
December 15, 2015
Cancer incidence and survival in Lynch syndrome patients receiving colonoscopic and gynaecological surveillance: first report from the prospective Lynch syndrome database
Pål Møller, Toni Seppälä, Inge Bernstein, et al.
Gut
|
June 5, 2016
Incidence of and survival after subsequent cancers in carriers of pathogenic MMR variants with previous cancer: a report from the prospective Lynch syndrome database
Pål Møller, Toni Seppälä, Inge Bernstein, et al.
Page
of 17
Search research articles
Search
Showing results (131-140 of 162) with videos related to
Sort By:
Page
of 17
The New England Journal of Medicine
|
December 17, 2008
Effect of aspirin or resistant starch on colorectal neoplasia in the Lynch syndrome
John Burn, D Timothy Bishop, Jukka-Pekka Mecklin, et al.
The New England Journal of Medicine
|
September 9, 2020
Eflornithine plus Sulindac for Prevention of Progression in Familial Adenomatous Polyposis
Carol A Burke, Evelien Dekker, Patrick Lynch, et al.
The Lancet. Oncology
|
November 13, 2012
Long-term effect of resistant starch on cancer risk in carriers of hereditary colorectal cancer: an analysis from the CAPP2 randomised controlled trial
John C Mathers, Mohammad Movahedi, Finlay Macrae, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 3, 2006
Germ line mutations of mismatch repair genes in hereditary nonpolyposis colorectal cancer patients with small bowel cancer: International Society for Gastrointestinal Hereditary Tumours Collaborative Study
Jae-Gahb Park, Duck-Woo Kim, Chang Won Hong, et al.
Science (New York, N.Y.)
|
November 8, 2008
GENETICS. The Human Variome Project
Richard G H Cotton, Arleen D Auerbach, Myles Axton, et al.
Human Mutation
|
February 12, 2019
A sensitive and scalable microsatellite instability assay to diagnose constitutional mismatch repair deficiency by sequencing of peripheral blood leukocytes
Richard Gallon, Barbara Mühlegger, Sören-Sebastian Wenzel, et al.
The British Journal of Surgery
|
May 9, 2024
Updated European guidelines for clinical management of familial adenomatous polyposis (FAP), MUTYH-associated polyposis (MAP), gastric adenocarcinoma, proximal polyposis of the stomach (GAPPS) and other rare adenomatous polyposis syndromes: a joint EHTG-ESCP revision
Gloria Zaffaroni, Alessandro Mannucci, Laura Koskenvuo, et al.
Lancet (London, England)
|
November 1, 2011
Long-term effect of aspirin on cancer risk in carriers of hereditary colorectal cancer: an analysis from the CAPP2 randomised controlled trial
John Burn, Anne-Marie Gerdes, Finlay Macrae, et al.
Gut
|
December 15, 2015
Cancer incidence and survival in Lynch syndrome patients receiving colonoscopic and gynaecological surveillance: first report from the prospective Lynch syndrome database
Pål Møller, Toni Seppälä, Inge Bernstein, et al.
Gut
|
June 5, 2016
Incidence of and survival after subsequent cancers in carriers of pathogenic MMR variants with previous cancer: a report from the prospective Lynch syndrome database
Pål Møller, Toni Seppälä, Inge Bernstein, et al.
Page
of 17